FDA Approved: SEROSTIM — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SEROSTIM (somatropin) from EMD Serono, Inc. to update the product labeling. The changes expand or modify indications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Wasting Syndrome
• Growth Hormone Deficiency
• Idiopathic Short Stature
• Noonan Syndrome
• Prader-willi Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• SEROSTIM (somatropin)

Snippet

SUPPL AP for SEROSTIM (SOMATROPIN)